[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349474-105":59,"doc-detail-349474-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","unraveling-the-implications-of-ulbp1-expression-from-pan-cancer-to-head-and-neck-squamous-cell-carcinoma","Unraveling the implications of ULBP1 expression from pan-cancer to head and neck squamous cell carcinoma","","UL-16 binding protein 1 (ULBP1), a ligand for the NK cell-stimulatory receptor NKG2D, is presented as a cell-surface protein on malignant cells. Across systematic bioinformatics analyses of 33 malignancies, ULBP1 dysregulation is linked to advanced tumor staging and survival, with ROC analysis supporting ULBP1 as a diagnostic biomarker. DNA/RNA methylation suggests epigenetic control and ULBP1 remodels tumor microenvironment. Experimental validation in head and neck squamous cell carcinoma shows oncogenic effects promoting migration, invasion, and proliferation while inhibiting apoptosis, alongside KRAS activation and EMT induction. Elevated ULBP1 is associated with improved outcomes after PD-1/PD-L1 blockade therapy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/unraveling-the-implications-of-ulbp1-expression-from-pan-cancer-to-head-and-neck-squamous-cell-carcinoma/349474/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/unraveling-the-implications-of-ulbp1-expression-from-pan-cancer-to-head-and-neck-squamous-cell-carcinoma/349474.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is ULBP1 and why is it biologically important in cancer?","Question",{"text":113,"@type":114},"ULBP1 is a ligand for the NKG2D receptor on immune cells. It is expressed on malignant cells and is implicated in cancer progression and immune regulation via NKG2D-related signaling.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does ULBP1 relate to tumor progression and patient survival in multiple cancers?",{"text":118,"@type":114},"Across analyses of 33 malignancies, ULBP1 dysregulation is associated with advanced tumor staging and patient survival outcomes. The study also reports diagnostic performance based on ROC analysis.",{"name":120,"@type":111,"acceptedAnswer":121},"What functional effects does ULBP1 have in head and neck squamous cell carcinoma (HNSCC)?",{"text":122,"@type":114},"In HNSCC models, ULBP1 overexpression promotes migration, invasion, and proliferation in vitro and in vivo, while inhibiting apoptosis. It is linked to EMT induction and KRAS pathway activation.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349474,1790228895,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nUnraveling the implications of ULBP1 expression from pan-cancer to head and neck squamous cell carcinoma  \nYu Peng1,3, Ye Zhou2,3, Cong Xu1,3, Lanzhen Cui1, Lijun Zhang1, Bin Di1􀀍 & Xiaoming Li1􀀍  \nUL-16 binding protein 1 (ULBP1), a ligand for the NK cell-stimulatory receptor NKG2D, is expressed as a cell-surface protein on malignant cells. While accumulating evidence links ULBP1 to cancer progression, its pan-cancer immunological and clinical significance remains underexplored. Through systematic bioinformatics analyses of 33 malignancies, we uncovered that widespread ULBP1 dysregulation across cancers was associated with advanced tumor staging and patient survival. ROC curve analysis further identified ULBP1 as a robust diagnostic biomarker. Subsequent exploration demonstrated ULBP1’s epigenetic regulation through DNA/RNA methylation and its influence on tumor microenvironment remodeling. Functional validation in head and neck squamous cell carcinoma (HNSCC) confirmed that ULBP1 overexpression promoted cellular migration, invasion, proliferation in vitro and in vivo, while inhibiting apoptosis, suggesting NK cell-independent oncogenic mechanisms. We discovered that ULBP1 protein was upregulated in HNSCC tissue, induced epithelial-mesenchymal transition (EMT), as well as activation of the KRAS signaling pathway. Intriguingly, elevated ULBP1 was correlated with improved clinical outcomes following PD-1/PD-L1 blockade therapy, indicating its potential as a predictive biomarker for checkpoint inhibitor response. This study comprehensively delineates ULBP1’s functional mechanisms across multiple cancers and experimentally validates its oncogenic role in HNSCC.  \nKeywords ULBP1, NKG2DL, Head and neck squamous cell carcinoma  \nLigands ofthe natural killer group 2D (NKG2DL) family exhibit highly restricted expression in healthy tissues but are widely expressed in tumors1. In humans, the NKG2DL family consists of MHC class I chain-related protein A/B (MICA/B) and UL16 binding protein 1–6 (ULBP1-6) molecules which are also known as retinoic acid early transcript (RAET) . Among the human NKG2D ligands, MICA, MICB, ULBP4-5 are type I transmembrane proteins, whereas ULBP1-3 and ULBP6 are glycosylphosphatidylinositol (GPI)-anchored proteins2. MICA/Bis primarily involved in the DNA damage response by serving as key ligands for natural killer (NK) cells and cytotoxic T lymphocytes, thereby mediating the recognition and elimination of DNA-damaged cells3,4. ULBP exerts its core function by specifically binding to the NKG2D receptor on the surface of NK cells, CD8⁺ T cells, and γδ T cells, thereby activating downstream signaling pathways to trigger the cytotoxic activity of these immune cells and mediate the recognition and lysis of stressed cells5. Nevertheless, serum NKG2D ligands have been shown to impair T cell function6, reducing NK cell activity by decreasing surface expression of NKG2D receptor7, and mediate tumor evasion by reducing peripheral NK cell numbers8. Together, NKG2DL exhibit dual immunoregulatory functions: activating immune responses to eliminate infected or malignant cells, while also facilitating immune evasion to circumvent immune surveillance.  \nUL16 binding protein 1 (ULBP1), recognized as a NKG2D ligand, has been previously implicated in modulating NK cell-mediated innate immune responses. Among several known NKG2D ligands, human cytomegalovirus infection was shown to induce ULBP1, ULBP2, and ULBP3 in human foreskin fibroblasts9. HIV-1 infection similarly induces the surface expression of ULBP1 and ULBP2 in primary CD4+ T-cells through the DNA damage response10. HCV induces the surface expression of ULBP1 in human hepatocytes, enabling  \n1Department of Otolaryngology Head and Neck Surgery, Bethune International Peace Hospital, Shijiazhuang 050081, Hebei Province, China. 2Department of General Surgery, Bethune International Peace Hospital, ","cbCaidP30KaWIRqF","https://ap.wps.com/l/cbCaidP30KaWIRqF","pdf",32010467,22,"English","# Introduction\n## NKG2D ligands and ULBP1 background\n## Study aims and scope\n# Results\n## ULBP1 expression across pan-cancer and clinical associations","[{\"question\":\"What is ULBP1 and why is it biologically important in cancer?\",\"answer\":\"ULBP1 is a ligand for the NKG2D receptor on immune cells. It is expressed on malignant cells and is implicated in cancer progression and immune regulation via NKG2D-related signaling.\"},{\"question\":\"How does ULBP1 relate to tumor progression and patient survival in multiple cancers?\",\"answer\":\"Across analyses of 33 malignancies, ULBP1 dysregulation is associated with advanced tumor staging and patient survival outcomes. The study also reports diagnostic performance based on ROC analysis.\"},{\"question\":\"What functional effects does ULBP1 have in head and neck squamous cell carcinoma (HNSCC)?\",\"answer\":\"In HNSCC models, ULBP1 overexpression promotes migration, invasion, and proliferation in vitro and in vivo, while inhibiting apoptosis. It is linked to EMT induction and KRAS pathway activation.\"}]","Unraveling the implications of ULBP1 expression from pan-cancer to head and neck squamous cell carcinoma | PDF",1790083477,55,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff9b26e03ea43eb1a32f244aa3b09041.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0577f58567401cdd6d7338bfde9ba23c.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2034dc6065c185b5829534e4d70b87ab.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d06cb7ade467c15623bb61f32f7d4d7.webp",980,1287]